Sorensen C M, Pierce C W
J Exp Med. 1981 Jul 1;154(1):35-47. doi: 10.1084/jem.154.1.35.
C57BL/10 mice were injected with semiallogeneic (B10.D2 X C57BL/10)F(1) spleen cells via the anterior facial vein within 24 h of birth to induce tolerance to B10.D2 (H-2(d)) alloantigens. Spleen cells from these mice as adults developed reduced, but significant, mixed lymphocyte and cytotoxic lymphocyte responses in vitro to H-2(d) stimulator cells and these treated mice rejected first-set B10.D2 skin grafts within a normal time-course, indicating that at best only a state of partial tolerance had been induced. Spleen cells from these mice failed to develop antibody responses to a variety of antigens in vitro when H-2(d) macrophages were in the cultures. Partially purified T cells from these neonatally treated mice suppressed primary antibody responses by normal syngeneic spleen cells in the presence of H-2(d) but not other allogeneic macrophages. These radiosensitive, haplotype-specific suppressor T (Ts) cells inhibited primary antibody responses by blocking initiation of the response, but failed to suppress secondary antibody responses and mixed lymphocyte or cytotoxic lymphocyte responses by appropriate responding spleen cells. To activate H-2(d) haplotype-specific Ts cells, stimulation with IA(d) subregion antigen(s) was necessary and sufficient; syngenicity at the I-A subregion of H-2 between the activated Ts cells and target responding spleen cell populations was also necessary and sufficient to achieve suppression. Comparable results have been obtained with spleen cells from BALB/c mice injected as neonates with (B10.D2 x C57BL/10)F(1) spleen cells where IA(b) antigens activate the haplotype-specific Ts cells. Implications for the significance of this population of haplotype-specific Ts cells in immune regulation are discussed and the properties of these Ts cells are compared and contrasted with other antigen-specific and nonspecific Ts cells whose activity is restricted by I- region products.
在出生后24小时内,通过面静脉给C57BL/10小鼠注射半同种异体(B10.D2×C57BL/10)F1脾细胞,以诱导对B10.D2(H-2(d))同种异体抗原的耐受性。这些成年小鼠的脾细胞在体外对H-2(d)刺激细胞产生的混合淋巴细胞反应和细胞毒性淋巴细胞反应有所降低,但仍很显著,并且这些经处理的小鼠在正常时间进程内排斥了首次移植的B10.D2皮肤移植物,这表明最多只诱导出了部分耐受状态。当培养物中有H-2(d)巨噬细胞时,这些小鼠的脾细胞在体外对多种抗原无法产生抗体反应。从这些新生期经处理的小鼠中部分纯化的T细胞,在有H-2(d)但无其他同种异体巨噬细胞存在的情况下,可抑制正常同基因脾细胞的初次抗体反应。这些对辐射敏感、单倍型特异性的抑制性T(Ts)细胞通过阻断反应的起始来抑制初次抗体反应,但无法抑制二次抗体反应以及相应反应脾细胞的混合淋巴细胞反应或细胞毒性淋巴细胞反应。要激活H-2(d)单倍型特异性Ts细胞,IA(d)亚区抗原的刺激是必要且充分的;激活的Ts细胞与靶反应脾细胞群体之间在H-2的I-A亚区的同基因性对于实现抑制也是必要且充分的。用新生期注射了(B10.D2×C·57BL/10)F1脾细胞的BALB/c小鼠的脾细胞也得到了类似结果,其中IA(b)抗原激活了单倍型特异性Ts细胞。本文讨论了这种单倍型特异性Ts细胞群体在免疫调节中的意义,并将这些Ts细胞的特性与其他其活性受I区产物限制的抗原特异性和非特异性Ts细胞进行了比较和对比。